Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 3 Observational 1

Sponsor

Conditions

Neoplasms 276 Breast Neoplasms 266 Lung Neoplasms 127 Prostatic Neoplasms 124 Colorectal Neoplasms 105 Carcinoma, Non-Small-Cell Lung 104 Pancreatic Neoplasms 70 Carcinoma, Hepatocellular 58 Stomach Neoplasms 55 Hematologic Neoplasms 52 Urinary Bladder Neoplasms 50 Multiple Myeloma 50 Ovarian Neoplasms 49 Brain Neoplasms 49 Esophageal Neoplasms 46 Leukemia, Myeloid, Acute 45 Melanoma 44 Head and Neck Neoplasms 42 Colonic Neoplasms 41 Disease 40 Neoplasm Metastasis 39 Liver Neoplasms 39 Rectal Neoplasms 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 32 Lymphoma 32 Uterine Cervical Neoplasms 31 Endometrial Neoplasms 30 Thyroid Neoplasms 29 Recurrence 29 Leukemia, Lymphocytic, Chronic, B-Cell 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × CRC × 90 days × Clear all

NCT03336658 2026-05-05

ITB

Insel Gruppe AG, University Hospital Bern

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡